Fundraising Fox

Longevity Series A Investors & VC Firms

155 firms in this list, with a median first check of $450K. 39 of them lead rounds. Generated from verified public data and updated continuously.

Able Partners
New York CitySeed–Series A$500K – $3M
3 people
Future Ventures
Los AltosPre-Seed–Series A$1M – $10M
5 people
Hadean Ventures
OsloSeed–Growth
21 people
Rising Tide
PacificaPre-Seed–Series B
5 people
O2h Ventures
CambridgePre-Seed–Series A
23 people
Northstar Ventures
Newcastle upon TynePre-Seed–Late Stage$38.1K – $1.3M
18 people
Delin Ventures
LondonPre-Seed–Series A$216K – $2.2M
21 people
Sciety
StockholmSeed–Growth
21 people
Exceptional Ventures
LondonPre-Seed–Series A
16 people
Westlake Village BioPartners
Los AngelesPre-Seed–Series A$100K – $5M
13 people
WMU Biosciences Research & Commercialization Center
KalamazooSeed–Series A$100K – $250K
12 people
Flagship Pioneering
CambridgeSeed–Series A$500K – $10M
5 people
UCL Technology Fund
LondonPre-Seed–Growth$320K – $9M
13 people
Better Ventures Central Llc
OaklandPre-Seed–Growth$500K – $1.5M
4 people
DCVC Bio
Palo AltoSeed–Growth
15 people
Tenmile
Seed–Growth
11 people
Medical Excellence Capital
New YorkPre-Seed–Series B
17 people
V-Bio Ventures
GhentSeed–Growth$270K – $2.2M
13 people
Maximon
ZugPre-Seed–Series A$11M
22 people
Spero Ventures
BurlingameSeed–Series A$2M – $4M
6 people
Noetic
TorontoSeed–Series A
10 people
PsyMed Ventures
BerkeleyPre-Seed–Series A
12 people
Elad Gil
San FranciscoSeed–Growth$100K – $10M
1 person
Kinled Holding
Hong KongSeed–Series A
1 person

Related lists

Data sourced from public filings and firms' own websites — see our methodology.